Doxorubicin-loaded PLGA Microparticles with Internal Pores for Long-acting Release in Pulmonary Tumor Inhalation Treatment

Citation: Tian-shi Feng, Hua-yu Tian, Cai-na Xu, Lin Lin, Michael Hon-Wah Lam, Hao-jun Liang, Xue-si Chen. Doxorubicin-loaded PLGA Microparticles with Internal Pores for Long-acting Release in Pulmonary Tumor Inhalation Treatment[J]. Chinese Journal of Polymer Science, 2015, 33(7): 947-954. doi: 10.1007/s10118-015-1642-y shu

Doxorubicin-loaded PLGA Microparticles with Internal Pores for Long-acting Release in Pulmonary Tumor Inhalation Treatment

1.
1. CAS Key Laboratory of Soft Matter Chemistry, Department of Polymer Science and Engineering, University of Science and Technology of China, Hefei 230026, China
2.
2. Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China
3.
3. Department of Biology and Chemistry, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong, China
4.
4. Advanced Laboratory of Environmental Research and Technology (ALERT), Joint Advanced Research Center, USTC-City U, Suzhou 215124, China
5.
6.
Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China
7.
1. Department of Biology and Chemistry, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong, China
8.
2. Advanced Laboratory of Environmental Research and Technology (ALERT), Joint Advanced Research Center, USTC-City U, Suzhou 215124, China
基金项目:
This work was financially supported by the National Natural Science Foundation of China (Nos. 51222307, 51303173, 51390480, 21474104 and 51403205), the Ministry of Science and Technology of China (International cooperation and communication program 2011DFR51090), Jilin Province Science and Technology Development Program (Nos. 20120306, 20130521011JH).

摘要: Doxorubicin (DOX) loaded poly(lactic-co-glycolic acid) (PLGA) microparticles with internal pores (MP-D) were developed for long-acting release in pulmonary inhalation treatment. The PLGA microparticles exhibited favorable aerodynamic properties for pulmonary delivery. In vitro drug release profile suggested that MP-D have the advantage of long-term maintenance of drug concentrations. MTT assay demonstrated the in vitro anti-tumor efficiency of the DOX loaded PLGA microparticles. Furthermore, melanoma lung metastasis model was established to determine the in vivo anti-tumor efficiency. The mice treated with MP-D showed significantly fewer lesions than the untreated ones. The survival analysis indicated that MP-D prolonged the survival time of tumor-bearing mice. These results suggested that DOX loaded PLGA microparticles with internal pores have the potential to be used as long-acting release carriers in clinical lung cancer treatment.

关键词:

English

Doxorubicin-loaded PLGA Microparticles with Internal Pores for Long-acting Release in Pulmonary Tumor Inhalation Treatment

1.
1. CAS Key Laboratory of Soft Matter Chemistry, Department of Polymer Science and Engineering, University of Science and Technology of China, Hefei 230026, China
2.
2. Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China
3.
3. Department of Biology and Chemistry, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong, China
4.
4. Advanced Laboratory of Environmental Research and Technology (ALERT), Joint Advanced Research Center, USTC-City U, Suzhou 215124, China
5.
6.
Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China
7.
1. Department of Biology and Chemistry, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong, China
8.
2. Advanced Laboratory of Environmental Research and Technology (ALERT), Joint Advanced Research Center, USTC-City U, Suzhou 215124, China
Received Date: 23 October 2014
Revised Date: 06 November 2014
Available Online: 05 July 2015
Fund Project:
This work was financially supported by the National Natural Science Foundation of China (Nos. 51222307, 51303173, 51390480, 21474104 and 51403205), the Ministry of Science and Technology of China (International cooperation and communication program 2011DFR51090), Jilin Province Science and Technology Development Program (Nos. 20120306, 20130521011JH).

Abstract: Doxorubicin (DOX) loaded poly(lactic-co-glycolic acid) (PLGA) microparticles with internal pores (MP-D) were developed for long-acting release in pulmonary inhalation treatment. The PLGA microparticles exhibited favorable aerodynamic properties for pulmonary delivery. In vitro drug release profile suggested that MP-D have the advantage of long-term maintenance of drug concentrations. MTT assay demonstrated the in vitro anti-tumor efficiency of the DOX loaded PLGA microparticles. Furthermore, melanoma lung metastasis model was established to determine the in vivo anti-tumor efficiency. The mice treated with MP-D showed significantly fewer lesions than the untreated ones. The survival analysis indicated that MP-D prolonged the survival time of tumor-bearing mice. These results suggested that DOX loaded PLGA microparticles with internal pores have the potential to be used as long-acting release carriers in clinical lung cancer treatment.

Key words:

1. [1]
  Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E. and Forman, D., Ca-Cancer J. Clin., 2011, 61(2): 69
2. [2]
  DeSantis, C.E., Lin, C.C., Mariotto, A.B., Siegel, R.L., Stein, K.D., Kramer, J.L., Alteri, R., Robbins, A.S. and Jemal, A., Ca-Cancer J. Clin., 2014, 64(4): 252
3. [3]
  Ungaro F., d' Angelo, I., Miro, A., La Rotonda, M.I. and Quaglia, F., J. Pharm. Pharmacol., 2012, 64(9): 1217
4. [4]
  Otterson, G.A., Villalona-Calero, M.A., Sharma, S., Kris, M.G., Imondi, A., Gerber, M., White, D.A., Ratain, M.J., Schiller, J.H., Sandler, A., Kraut, M., Mani, S. and Murren, J.R., Clin. Cancer Res., 2007, 13(4): 1246
5. [5]
  Germershaus, O., Schultz, I., Luhmann, T., Beck-Broichsitter, M., Hogger, P. and Meinel, L., Eur. J. Pharm. Biopharm., 2013, 85(1): 61
6. [6]
  Xu, C.N., Tian, H.Y. and Chen, X.S., Chinese J. Chem., 2014, 32(1): 13
7. [7]
  Bruinenberg, P., Serisier, D., Cipolla, D. and Blanchard, J., Am. J. Resp. Crit. Care, 2010, 181
8. [8]
  Cipolla, D., Shekunov, B., Blanchard, J. and Hickey, A., Adv. Drug Deliv. Rev., 2014, 75C: 53
9. [9]
  Kim, I., Byeon, H.J., Kim, T.H., Lee, E.S., Oh, K.T., Shin, B.S., Lee, K.C. and Youn, Y.S., Biomaterials, 2013, 34(27): 6444
10. [10]
  Kim, I., Byeon, H.J., Kim, T.H., Lee, E.S., Oh, K.T., Shin, B.S., Lee, K.C. and Youn, Y.S., Biomaterials, 2012, 33(22): 5574
11. [11]
  Chow, A.H.L., Tong, H.H.Y., Chattopadhyay, P. and Shekunov, B.Y., Pharm. Res., 2007, 24(3): 411
12. [12]
  Lee, S.H., Teo, J., Heng, D., Ng, W.K., Chan, H.K. and Tan, R.B.H., Eur. J. Pharm. Biopharm., 2013, 83(2): 275
13. [13]
  Islam, N. and Gladki, E., Int. J. Pharmaceut., 2008, 360(1-2): 1
14. [14]
  Roche, N., Dessanges, J.F. and Dubus, J.C., Rev. Mal. Respir., 2005, 22(4): 605
15. [15]
  Onoue, S., Sato, H., Ogawa, K., Kojo, Y., Aoki, Y., Kawabata, Y., Wada, K., Mizumoto, T. and Yamada, S., Eur. J. Pharm. Biopharm., 2012, 80(1): 54
16. [16]
  Tashkin, D.P., Rennard, S.I., Martin, P., Ramachandran, S., Martin, U.J., Silkoff, P.E. and Goldman, M., Drugs, 2008, 68(14): 1975
17. [17]
  Westerman, E.M., De Boer, A.H., Le Brun, P.P.H, Touw, D.J., Roldaan, A.C., Frijlink, H.W. and Heijerman, H.G.M., J. Cyst. Fibros., 2007, 6(4): 284
18. [18]
  Chan, J.G.Y., Chan, H.K., Prestidge, C.A., Denman, J.A., Young, P.M. and Traini, D., Eur. J. Pharm. Biopharm., 2013, 83(2): 285
19. [19]
  Meenach, S.A., Anderson, K.W., Hilt, J.Z., McGarry, R.C. and Mansour, H.M., Eur. J. Pharm. Sci., 2013, 49(4): 699
20. [20]
  Yang, Y., Bajaj, N., Xu, P., Ohn, K., Tsifansky, M.D. and Yeo, Y., Biomaterials, 2009, 30(10): 1947
21. [21]
  Rawat, A., Majumder, Q.H. and Ahsan, F., J. Control. Release, 2008, 128(3): 224
22. [22]
  Park, S., Kwag, D.S., Lee, U.Y., Lee, D.J., Oh, K.T., Youn, Y.S., and Lee, E.S., Polym. Adv. Technol., 2014, 25(1): 16
23. [23]
  Chen, A.Z., Zhao, C., Wang, S.B., Liu, Y.G. and Lin, D.L., J. Mater. Chem. B, 2013, 1(23): 2967
24. [24]
  Fan, J.B., Huang, C., Jiang, L. and Wang, S.T., J. Mater. Chem. B, 2013, 1(17): 2222
25. [25]
  Wang, F., Wang, Y.C., Dou, S., Xiong, M.H., Sun, T.M. and Wang, J., ACS Nano, 2011, 5(5): 3679
26. [26]
  Chu, Y.F., Yu, H., Ma, Y.Y., Zhang, Y.T., Chen, W.H., Zhang, G.Y., Wei, H., Zhang, X.Z., Zhuo, R.X. and Jiang, X.L., J. Polym. Sci., Part A: Polym. Chem., 2014, 52(13): 1771
27. [27]
  Esteve, P.O., Chin, H.G. and Pradhan, S., J. Biol. Chem., 2007, 282(4): 2615
28. [28]
  Liao, C.D., Sun, Q.Q., Liang, B.L., Shen, J. and Shuai, X.T., Eur. J. Radiol., 2011, 80(3): 699
29. [29]
  Fan, H., Hu, Q.D., Xu, F.J., Liang, W.Q., Tang, G.P. and Yang, W.T., Biomaterials, 2012, 33(5): 1428
30. [30]
  Zhang, L.Z., Zhang, Y.J., Wu, W. and Jiang, X.Q., Chinese J. Polym. Sci., 2013, 31(5): 778
31. [31]
  Lee, J., Oh, Y.J., Lee, S.K. and Lee, K.Y., J. Control. Release, 2010, 146(1): 61
32. [32]
  Kim, H., Lee, J., Kim, T.H., Lee, E.S., Oh, K.T., Lee, D.H., Park, E.S., Bae, Y.H., Lee, K.C. and Youn, Y.S., Pharm. Res., 2011, 28(8): 2008
33. [33]
  Fan, J.B., Song, Y.Y., Wang, S.T., Jiang, L., Zhu, M.Q. and Guo, X.L., RSC Adv., 2014, 4(2): 629
34. [34]
  Qian, Q.P., Huang, X.P., Zhang, X.Y., Xie, Z.G. and Wang, Y.P., Angew. Chem. Int. Ed., 2013, 52(40): 10625
35. [35]
  Edwards, D.A., Hanes, J., Caponetti, G., Hrkach, J., BenJebria, A., Eskew, M.L., Mintzes, J., Deaver, D., Lotan, N. and Langer, R., Science, 1997, 276(5320): 1868

扫一扫看文章

计量

PDF下载量: 0
文章访问数: 799
HTML全文浏览量: 33

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Doxorubicin-loaded PLGA Microparticles with Internal Pores for Long-acting Release in Pulmonary Tumor Inhalation Treatment

English

Doxorubicin-loaded PLGA Microparticles with Internal Pores for Long-acting Release in Pulmonary Tumor Inhalation Treatment

CCS Chemistry：嵌段共聚物自组装成 “三明治”二维有机材料，实现纳米级压力传感功能

CCS Chemistry：颜徐州、鲍哲南：你的皮肤可能是一片SPMs

CCS Chemistry：工作高效不疲劳，只须让催化剂动起来

CCS Chemistry：静电组装导向聚合- 聚电解质纳米凝胶量化制备新策略

CCS Chemistry：金黄色葡萄球菌醛基脱氢酶是如何识别特异性底物的？

计量

通讯作者: 陈斌, bchen63@163.com

中国化学会秘书处

Doxorubicin-loaded PLGA Microparticles with Internal Pores for Long-acting Release in Pulmonary Tumor Inhalation Treatment

English

Doxorubicin-loaded PLGA Microparticles with Internal Pores for Long-acting Release in Pulmonary Tumor Inhalation Treatment

CCS Chemistry：嵌段共聚物自组装成 “三明治”二维有机材料，实现纳米级压力传感功能

CCS Chemistry：颜徐州、鲍哲南： 你的皮肤可能是一片SPMs

CCS Chemistry：工作高效不疲劳，只须让催化剂动起来

CCS Chemistry：静电组装导向聚合- 聚电解质纳米凝胶量化制备新策略

CCS Chemistry：金黄色葡萄球菌醛基脱氢酶是如何识别特异性底物的？

计量

文章相关

通讯作者: 陈斌, bchen63@163.com

中国化学会秘书处

CCS Chemistry：颜徐州、鲍哲南：你的皮肤可能是一片SPMs